🇺🇸 FDA
Patent

US 10849982

C3-carbon linked glutarimide degronimers for target protein degradation

granted A61KA61K31/45A61K31/451

Quick answer

US patent 10849982 (C3-carbon linked glutarimide degronimers for target protein degradation) held by C4 THERAPEUTICS, INC. expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
C4 THERAPEUTICS, INC.
Grant date
Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/45, A61K31/451, A61K31/454, A61K31/4545